Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 12, 2021New England Journal of MedicineOpen Access

BNT162b2-Elicited Neutralization against New SARS-CoV-2 Spike Variants

View Full Paper
Ask AI
Bookmark
Share

Authors

YLYang LiuLiaocheng UniversityJLJianying LiuFudan UniversityHXHongjie XiaBoston University

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Liu et al. (2021) studied this question.

synapsesocial.com/papers/6a72105a5671bbf00bc30215https://doi.org/10.1056/nejmc2106083
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Neutralizing Activity of BNT162b2-Elicited Serum2021 · 634 citations
  2. 2BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans2020 · 171 citations
  3. 3Acquisition of the L452R Mutation in the ACE2-Binding Interface of Spike Protein Triggers Recent Massive Expansion of SARS-CoV-2 Variants2021 · 192 citations
  4. 4Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine2020 · 15,765 citations
  5. 5A single BNT162b2 mRNA dose elicits antibodies with Fc-mediated effector functions and boost pre-existing humoral and T cell responses2021 · 49 citations